{"transactions":[{"id":857114,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":62425,"kind":"person","name":"Calafiore Massimo","position":1,"cik":"0001828602","reported_name":"Calafiore Massimo","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-03-06T16:17:51.000Z","date":"2026-03-05","kind":"sale","planned":false,"acquired":false,"shares":6031,"price":12.5508,"value":75693.8748,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.48 to $12.72, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 221,042 previously reported restricted stock units."}],"balance_after":320136,"source":{"system":"sec-edgar","filing":"0001193125-26-096583","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1828602/000119312526096583/ownership.xml","form_type":"4"}},{"id":857113,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":62425,"kind":"person","name":"Calafiore Massimo","position":1,"cik":"0001828602","reported_name":"Calafiore Massimo","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-03-06T16:17:51.000Z","date":"2026-03-04","kind":"sale","planned":false,"acquired":false,"shares":6189,"price":12.9163,"value":79938.9807,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.80 to $13.03, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 221,042 previously reported restricted stock units."}],"balance_after":326167,"source":{"system":"sec-edgar","filing":"0001193125-26-096583","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1828602/000119312526096583/ownership.xml","form_type":"4"}},{"id":859885,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":62425,"kind":"person","name":"Calafiore Massimo","position":1,"cik":"0001828602","reported_name":"Calafiore Massimo","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-05T18:52:33.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":273279,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first, second and third anniversary of the Grant Date."}],"balance_after":273279,"derivative":{"exercise_price":13.03,"expiration_date":"2033-03-03","underlying":"Common Stock","underlying_shares":273279},"source":{"system":"sec-edgar","filing":"0001193125-26-094480","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1828602/000119312526094480/ownership.xml","form_type":"4"}},{"id":859884,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":62425,"kind":"person","name":"Calafiore Massimo","position":1,"cik":"0001828602","reported_name":"Calafiore Massimo","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-03-05T18:52:33.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":115119,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units approved by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered thereby on the first, second and third anniversary of the Grant Date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 135,369 previously reported restricted stock units."}],"balance_after":332356,"source":{"system":"sec-edgar","filing":"0001193125-26-094480","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1828602/000119312526094480/ownership.xml","form_type":"4"}},{"id":940424,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":62425,"kind":"person","name":"Calafiore Massimo","position":1,"cik":"0001828602","reported_name":"Calafiore Massimo","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-01-13T17:46:07.000Z","date":"2026-01-12","kind":"sale","planned":false,"acquired":false,"shares":9797,"price":15.2138,"value":149049.5986,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.02 to $15.75, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 135,369 previously reported deferred stock units and an aggregate of 2,031 shares acquired under Orthofix's Stock Purchase Plan on 10/31/2025."}],"balance_after":217237,"source":{"system":"sec-edgar","filing":"0001193125-26-011929","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1828602/000119312526011929/ownership.xml","form_type":"4"}},{"id":940423,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":62425,"kind":"person","name":"Calafiore Massimo","position":1,"cik":"0001828602","reported_name":"Calafiore Massimo","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-01-13T17:46:07.000Z","date":"2026-01-09","kind":"sale","planned":false,"acquired":false,"shares":9600,"price":15.8235,"value":151905.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.57 to $16.15, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 135,369 previously reported deferred stock units and an aggregate of 2,031 shares acquired under Orthofix's Stock Purchase Plan on 10/31/2025."}],"balance_after":227034,"source":{"system":"sec-edgar","filing":"0001193125-26-011929","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1828602/000119312526011929/ownership.xml","form_type":"4"}},{"id":1152959,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":62425,"kind":"person","name":"Calafiore Massimo","position":1,"cik":"0001828602","reported_name":"Calafiore Massimo","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-05-12T19:14:09.000Z","date":"2025-05-09","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":12.54,"value":125400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price. The range of prices for these transactions was $12.41 to $12.755. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 182,396 previously reported restricted stock units and 2,199 shares acquired under Orthofix's Stock Purchase Plan on 4/30/2025."}],"balance_after":234603,"source":{"system":"sec-edgar","filing":"0000950170-25-069583","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1828602/000095017025069583/ownership.xml","form_type":"4"}},{"id":1220777,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":62425,"kind":"person","name":"Calafiore Massimo","position":1,"cik":"0001828602","reported_name":"Calafiore Massimo","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-03-06T16:27:08.000Z","date":"2025-03-05","kind":"purchase","planned":false,"acquired":true,"shares":9914,"price":17.43,"value":172801.02,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price. The range of prices for these transactions was $17.265 to $17.595. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 182,396 previously reported restricted stock units."}],"balance_after":222404,"source":{"system":"sec-edgar","filing":"0000950170-25-034737","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1828602/000095017025034737/ownership.xml","form_type":"4"}},{"id":1224612,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":62425,"kind":"person","name":"Calafiore Massimo","position":1,"cik":"0001828602","reported_name":"Calafiore Massimo","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-03-05T16:15:16.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":209541,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first, second and third anniversary of the Grant Date."}],"balance_after":209541,"derivative":{"exercise_price":16.98,"expiration_date":"2032-03-03","underlying":"Common Stock","underlying_shares":209541},"source":{"system":"sec-edgar","filing":"0000950170-25-033593","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1828602/000095017025033593/ownership.xml","form_type":"4"}},{"id":1224611,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":62425,"kind":"person","name":"Calafiore Massimo","position":1,"cik":"0001828602","reported_name":"Calafiore Massimo","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-03-05T16:15:16.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":88339,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 94,057 previously reported restricted stock units."}],"balance_after":212490,"source":{"system":"sec-edgar","filing":"0000950170-25-033593","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1828602/000095017025033593/ownership.xml","form_type":"4"}},{"id":1303951,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":62425,"kind":"person","name":"Calafiore Massimo","position":1,"cik":"0001828602","reported_name":"Calafiore Massimo","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-01-14T16:27:50.000Z","date":"2025-01-13","kind":"sale","planned":false,"acquired":false,"shares":9203,"price":17.1419,"value":157756.9057,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.79 to $17.27, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 94,057 previously reported restricted stock units."}],"balance_after":124151,"source":{"system":"sec-edgar","filing":"0000950170-25-005369","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1828602/000095017025005369/ownership.xml","form_type":"4"}},{"id":1303950,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":62425,"kind":"person","name":"Calafiore Massimo","position":1,"cik":"0001828602","reported_name":"Calafiore Massimo","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-01-14T16:27:50.000Z","date":"2025-01-10","kind":"sale","planned":false,"acquired":false,"shares":10078,"price":16.8306,"value":169618.7868,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.525 to $17.08, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 94,057 previously reported restricted stock units."}],"balance_after":133354,"source":{"system":"sec-edgar","filing":"0000950170-25-005369","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1828602/000095017025005369/ownership.xml","form_type":"4"}},{"id":1682018,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":62425,"kind":"person","name":"Calafiore Massimo","position":1,"cik":"0001828602","reported_name":"Calafiore Massimo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-01-10T17:03:13.000Z","date":"2024-01-08","kind":"grant","planned":false,"acquired":false,"shares":392005,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first anniversary of the Grant Date and one-twelfth (1/12th) of the shares covered thereby on each of the 15-month, 18-month, 21-month, 24-month, 27-month, 30-month, 33-month and 36-month anniversaries of the Grant Date, subject in each case to an additional vesting requirement related to the performance of the Company's common stock."}],"balance_after":392005,"derivative":{"exercise_price":13.29,"expiration_date":"2031-01-08","underlying":"Common Stock","underlying_shares":392005},"source":{"system":"sec-edgar","filing":"0001209191-24-001366","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1828602/000120919124001366/doc4.xml","form_type":"4"}},{"id":1682017,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":62425,"kind":"person","name":"Calafiore Massimo","position":1,"cik":"0001828602","reported_name":"Calafiore Massimo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-01-10T17:03:13.000Z","date":"2024-01-08","kind":"grant","planned":false,"acquired":true,"shares":141084,"price":13.29,"value":1875006.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date."}],"balance_after":141084,"source":{"system":"sec-edgar","filing":"0001209191-24-001366","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1828602/000120919124001366/doc4.xml","form_type":"4"}},{"id":2357566,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":62425,"kind":"person","name":"Calafiore Massimo","position":1,"cik":"0001828602","reported_name":"Calafiore Massimo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"RSUs","published_at":"2022-03-03T17:47:31.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":11008,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This RSU award was granted to the Reporting Person on March 1, 2022. In accordance with the terms of the RSU award, the award will vest in full on March 1, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"This RSU award was granted to the Reporting Person on March 1, 2022. In accordance with the terms of the RSU award, the award will vest in full on March 1, 2025."}],"balance_after":11008,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11008},"source":{"system":"sec-edgar","filing":"0001209191-22-015757","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1828602/000120919122015757/doc4.xml","form_type":"4"}},{"id":2357565,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":62425,"kind":"person","name":"Calafiore Massimo","position":1,"cik":"0001828602","reported_name":"Calafiore Massimo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"RSUs","published_at":"2022-03-03T17:47:31.000Z","date":"2022-03-01","kind":"exercise","acquired":false,"shares":5558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This RSU award was granted to the Reporting Person on March 1, 2019. In accordance with the terms of the RSU award, the award vested as to 5,558 shares on March 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"This RSU award was granted to the Reporting Person on March 1, 2019. In accordance with the terms of the RSU award, the award vested as to 5,558 shares on March 1, 2022."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":5558},"source":{"system":"sec-edgar","filing":"0001209191-22-015757","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1828602/000120919122015757/doc4.xml","form_type":"4"}},{"id":2357564,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":62425,"kind":"person","name":"Calafiore Massimo","position":1,"cik":"0001828602","reported_name":"Calafiore Massimo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"PRSUs","published_at":"2022-03-03T17:47:31.000Z","date":"2022-03-01","kind":"exercise","acquired":false,"shares":3141,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Each Performance Restricted Stock Unit (\"PRSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This PRSU award was granted to the Reporting Person on March 1, 2019. In accordance with the terms of the PRSU award, the award vested as to 3,141 shares on March 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This PRSU award was granted to the Reporting Person on March 1, 2019. In accordance with the terms of the PRSU award, the award vested as to 3,141 shares on March 1, 2022."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3141},"source":{"system":"sec-edgar","filing":"0001209191-22-015757","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1828602/000120919122015757/doc4.xml","form_type":"4"}},{"id":2357563,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":62425,"kind":"person","name":"Calafiore Massimo","position":1,"cik":"0001828602","reported_name":"Calafiore Massimo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-03-03T17:47:31.000Z","date":"2022-03-01","kind":"tax_withholding","acquired":false,"shares":3088,"price":54.51,"value":168326.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld by the Issuer to satisfy tax withholding obligations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Amount includes 555 shares acquired under the Issuer's employee stock purchase plan in April 2021."}],"balance_after":7207,"source":{"system":"sec-edgar","filing":"0001209191-22-015757","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1828602/000120919122015757/doc4.xml","form_type":"4"}},{"id":2357562,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":62425,"kind":"person","name":"Calafiore Massimo","position":1,"cik":"0001828602","reported_name":"Calafiore Massimo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-03-03T17:47:31.000Z","date":"2022-03-01","kind":"exercise","acquired":true,"shares":8699,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Amount includes 555 shares acquired under the Issuer's employee stock purchase plan in April 2021."}],"balance_after":10295,"source":{"system":"sec-edgar","filing":"0001209191-22-015757","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1828602/000120919122015757/doc4.xml","form_type":"4"}},{"id":2399628,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":62425,"kind":"person","name":"Calafiore Massimo","position":1,"cik":"0001828602","reported_name":"Calafiore Massimo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"PRSUs","published_at":"2022-02-14T17:49:43.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":3141,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Performance Restricted Stock Unit (\"PRSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This PRSU award was granted to the Reporting Person on March 1, 2019. The award was granted based on a target number of shares with a performance multiplier of 0-200% based on the Issuer's non-GAAP Operating Margin over the performance period ended December 31, 2021. On February 10, 2022, the Compensation Committee of the Issuer's Board of Directors certified the Issuer's performance for purposes of the award. Based on the Issuer's performance, the award will vest as to 3,141 shares on March 1, 2022, subject to and in accordance with the terms of the award. As the award did not constitute a derivative security, it was not required to be reported and was not reported on a Form 4 at the time of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This PRSU award was granted to the Reporting Person on March 1, 2019. The award was granted based on a target number of shares with a performance multiplier of 0-200% based on the Issuer's non-GAAP Operating Margin over the performance period ended December 31, 2021. On February 10, 2022, the Compensation Committee of the Issuer's Board of Directors certified the Issuer's performance for purposes of the award. Based on the Issuer's performance, the award will vest as to 3,141 shares on March 1, 2022, subject to and in accordance with the terms of the award. As the award did not constitute a derivative security, it was not required to be reported and was not reported on a Form 4 at the time of grant."}],"balance_after":3141,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3141},"source":{"system":"sec-edgar","filing":"0001209191-22-009438","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1828602/000120919122009438/doc4.xml","form_type":"4"}},{"id":2580489,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":62425,"kind":"person","name":"Calafiore Massimo","position":1,"cik":"0001828602","reported_name":"Calafiore Massimo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"RSUs","published_at":"2021-09-03T17:47:46.000Z","date":"2021-09-01","kind":"exercise","acquired":false,"shares":1419,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This RSU award was granted to the Reporting Person on September 4, 2018. In accordance with the terms of the RSU award, the award vested as to 1,419 shares on September 1, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This RSU award was granted to the Reporting Person on September 4, 2018. In accordance with the terms of the RSU award, the award vested as to 1,419 shares on September 1, 2021."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1419},"source":{"system":"sec-edgar","filing":"0001209191-21-054852","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1828602/000120919121054852/doc4.xml","form_type":"4"}},{"id":2580488,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":62425,"kind":"person","name":"Calafiore Massimo","position":1,"cik":"0001828602","reported_name":"Calafiore Massimo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-09-03T17:47:46.000Z","date":"2021-09-01","kind":"tax_withholding","acquired":false,"shares":490,"price":62.15,"value":30453.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld by the Issuer to satisfy tax withholding obligations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards."}],"balance_after":1596,"source":{"system":"sec-edgar","filing":"0001209191-21-054852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1828602/000120919121054852/doc4.xml","form_type":"4"}},{"id":2580487,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":62425,"kind":"person","name":"Calafiore Massimo","position":1,"cik":"0001828602","reported_name":"Calafiore Massimo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-09-03T17:47:46.000Z","date":"2021-09-01","kind":"exercise","acquired":true,"shares":1419,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards."}],"balance_after":2086,"source":{"system":"sec-edgar","filing":"0001209191-21-054852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1828602/000120919121054852/doc4.xml","form_type":"4"}},{"id":2719567,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":62425,"kind":"person","name":"Calafiore Massimo","position":1,"cik":"0001828602","reported_name":"Calafiore Massimo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Business Units"}}],"security":"Common Stock","published_at":"2021-05-11T17:55:22.000Z","date":"2021-05-07","kind":"sale","acquired":false,"shares":3399,"price":68.23,"value":231913.77,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale effected pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person, which is intended to comply with Rule 10b5-1."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards."}],"balance_after":667,"source":{"system":"sec-edgar","filing":"0001209191-21-031813","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1828602/000120919121031813/doc4.xml","form_type":"4"}},{"id":2731522,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":62425,"kind":"person","name":"Calafiore Massimo","position":1,"cik":"0001828602","reported_name":"Calafiore Massimo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Business Units"}}],"security":"RSUs","published_at":"2021-05-04T17:51:51.000Z","date":"2021-04-30","kind":"exercise","acquired":false,"shares":4699,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This RSU award was granted to the Reporting Person on April 30, 2018. In accordance with the terms of the RSU award, the award vested as to 4,699 shares on April 30, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4699},"source":{"system":"sec-edgar","filing":"0001209191-21-030001","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1828602/000120919121030001/doc4.xml","form_type":"4"}},{"id":2731521,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":62425,"kind":"person","name":"Calafiore Massimo","position":1,"cik":"0001828602","reported_name":"Calafiore Massimo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Business Units"}}],"security":"PRSUs","published_at":"2021-05-04T17:51:51.000Z","date":"2021-04-30","kind":"exercise","acquired":false,"shares":494,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Each Performance Restricted Stock Unit (\"PRSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This PRSU award was granted to the Reporting Person on April 30, 2018. In accordance with the terms of the PRSU award, the award vested as to 494 shares on April 30, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This PRSU award was granted to the Reporting Person on April 30, 2018. In accordance with the terms of the PRSU award, the award vested as to 494 shares on April 30, 2021."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":494},"source":{"system":"sec-edgar","filing":"0001209191-21-030001","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1828602/000120919121030001/doc4.xml","form_type":"4"}},{"id":2731520,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":62425,"kind":"person","name":"Calafiore Massimo","position":1,"cik":"0001828602","reported_name":"Calafiore Massimo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Business Units"}}],"security":"Common Stock","published_at":"2021-05-04T17:51:51.000Z","date":"2021-04-30","kind":"tax_withholding","acquired":false,"shares":1794,"price":71.45,"value":128181.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld by the Issuer to satisfy tax withholding obligations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Amount includes 555 shares acquired under the Issuer's employee stock purchase plan in April 2021."}],"balance_after":4066,"source":{"system":"sec-edgar","filing":"0001209191-21-030001","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1828602/000120919121030001/doc4.xml","form_type":"4"}},{"id":2731519,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":62425,"kind":"person","name":"Calafiore Massimo","position":1,"cik":"0001828602","reported_name":"Calafiore Massimo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Business Units"}}],"security":"Common Stock","published_at":"2021-05-04T17:51:51.000Z","date":"2021-04-30","kind":"exercise","acquired":true,"shares":5193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Amount includes 555 shares acquired under the Issuer's employee stock purchase plan in April 2021."}],"balance_after":5860,"source":{"system":"sec-edgar","filing":"0001209191-21-030001","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1828602/000120919121030001/doc4.xml","form_type":"4"}},{"id":2749901,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":62425,"kind":"person","name":"Calafiore Massimo","position":1,"cik":"0001828602","reported_name":"Calafiore Massimo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Business Units"}}],"security":"Common Stock","published_at":"2021-04-14T17:53:37.000Z","date":"2021-04-12","kind":"sale","acquired":false,"shares":3498,"price":68.19,"value":238528.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale effected pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person, which is intended to comply with Rule 10b5-1."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards."}],"balance_after":112,"source":{"system":"sec-edgar","filing":"0001209191-21-026691","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1828602/000120919121026691/doc4.xml","form_type":"4"}},{"id":2816747,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":62425,"kind":"person","name":"Calafiore Massimo","position":1,"cik":"0001828602","reported_name":"Calafiore Massimo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Business Units"}}],"security":"RSUs","published_at":"2021-03-03T17:51:19.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":7315,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This RSU award was granted to the Reporting Person on March 1, 2021. In accordance with the terms of the RSU award, the award will vest in full on March 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This RSU award was granted to the Reporting Person on March 1, 2021. In accordance with the terms of the RSU award, the award will vest in full on March 1, 2024."}],"balance_after":7315,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":7315},"source":{"system":"sec-edgar","filing":"0001209191-21-017150","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1828602/000120919121017150/doc4.xml","form_type":"4"}},{"id":2864691,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":62425,"kind":"person","name":"Calafiore Massimo","position":1,"cik":"0001828602","reported_name":"Calafiore Massimo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Business Units"}}],"security":"PRSUs","published_at":"2021-02-12T17:51:22.000Z","date":"2021-02-10","kind":"grant","acquired":true,"shares":494,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Performance Restricted Stock Unit (\"PRSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This PRSU award was granted to the Reporting Person on April 30, 2018. The award was granted based on a target number of shares with a performance multiplier of 0-200% based on the Issuer's non-GAAP Operating Margin over the performance period ended December 31, 2020. On February 10, 2021, the Compensation Committee of the Issuer's Board of Directors certified the Issuer's performance for purposes of the award. Based on the Issuer's performance, the award will vest as to 494 shares on April 30, 2021, subject to and in accordance with the terms of the award. As the award did not constitute a derivative security, it was not required to be reported and was not reported on a Form 4 at the time of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This PRSU award was granted to the Reporting Person on April 30, 2018. The award was granted based on a target number of shares with a performance multiplier of 0-200% based on the Issuer's non-GAAP Operating Margin over the performance period ended December 31, 2020. On February 10, 2021, the Compensation Committee of the Issuer's Board of Directors certified the Issuer's performance for purposes of the award. Based on the Issuer's performance, the award will vest as to 494 shares on April 30, 2021, subject to and in accordance with the terms of the award. As the award did not constitute a derivative security, it was not required to be reported and was not reported on a Form 4 at the time of grant."}],"balance_after":494,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":494},"source":{"system":"sec-edgar","filing":"0001209191-21-010348","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1828602/000120919121010348/doc4.xml","form_type":"4"}}]}